Symmetry Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,728
Closed -$572K 305
2026
Q1
$572K Sell
2,728
-153
-5% -$38.5K 0.03% 97
2025
Q4
$819K Sell
2,881
-285
-9% -$89.1K 0.05% 81
2025
Q3
$977K Sell
3,166
-277
-8% -$86.8K 0.11% 69
2025
Q2
$1.08M Sell
3,443
-131
-4% -$37.8K 0.13% 62
2025
Q1
$939K Sell
3,574
-108
-3% -$29.2K 0.13% 64
2024
Q4
$961K Sell
3,682
-286
-7% -$72K 0.14% 63
2024
Q3
$924K Buy
+3,968
New +$815K 0.22% 48

Other funds holding PODD

Symmetry Partners's PODD Position: Q2 2026 in Review

Symmetry Partners sold out of Insulet (PODD) in Q2 2026, closing a stake of 2,728 shares — an estimated $572K sold.

Symmetry Partners first reported a position in PODD in Q3 2024 and held it in 7 quarters. The position peaked at $1.08M in Q2 2025. 730 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Symmetry Partners reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Symmetry Partners sold 2,728 Insulet shares in Q2 2026, an estimated $572K.
  • Symmetry Partners first reported a position in Insulet in Q3 2024 and held it in 7 quarters.
  • Symmetry Partners's Insulet position peaked at $1.08M in Q2 2025.
  • 730 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Symmetry Partners's 13F filing for Q2 2026, filed 23 Jul 2026.